Apretude
Apretude is a prescription medicine used for HIV-1 PrEP to reduce the risk of getting HIV-1 infection in adults and adolescents who weigh at least 77 pounds (at least 35 kg). It is the first and only long-acting, injectable PrEP for reducing the risk of getting HIV. Designed to continuously help prevent the risk of getting HIV when taken every other month. No daily PrEP pills to remember or keep track of while you are receiving your Apretude injection every other month.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: GlaxoSmithKline |
CLASS: HIV PrEP |
PRESCRIBED BY: Infectious Disease |
HOW ADMINISTERED: Injection |
FREQUENCY: Administered one month apart for two consecutive months, then once every other month. |
Length of infusion: N/A |
FOR MORE INFORMATION: |
